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it remains unclear whether causal, rather than merely 
correlational, relationships in molecular networks can be 
inferred in complex biological settings. here we describe  
the hPn-dreAm network inference challenge, which focused  
on learning causal influences in signaling networks.  
We used phosphoprotein data from cancer cell lines as well 
as in silico data from a nonlinear dynamical model. using the 
phosphoprotein data, we scored more than 2,000 networks 
submitted by challenge participants. the networks spanned 
32 biological contexts and were scored in terms of causal 
validity with respect to unseen interventional data. A number 
of approaches were effective, and incorporating known biology 
was generally advantageous. Additional sub-challenges 
considered time-course prediction and visualization. our results 
suggest that learning causal relationships may be feasible 
in complex settings such as disease states. Furthermore, our 
scoring approach provides a practical way to empirically assess 
inferred molecular networks in a causal sense.
Molecular networks are central to biological function, and the 
data-driven learning of regulatory connections in molecular 
networks has long been a key topic in computational biology1–6. 
An emerging notion is that networks describing a certain bio-
logical process (e.g., signal transduction or gene regulation) may 
depend on biological contexts such as cell type, tissue type and 
disease state7,8. This has motivated efforts to elucidate networks 
that are specific to such contexts9–14. In disease settings, networks 
specific to disease contexts could improve understanding of the 
underlying biology and potentially be exploited to inform rational 
therapeutic interventions.
In this study we considered inference of causal molecular net-
works, focusing specifically on signaling downstream of receptor 
tyrosine kinases. We define edges in causal molecular networks 
(‘causal edges’) as directed links between nodes in which inhibi-
tion of the parent node can lead to a change in the abundance 
of the child node (Fig. 1a), either by direct interaction or via 
unmeasured intermediate nodes (Fig. 1b). Such edges may be 
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specific to biological context (Fig. 1c). The notion of a causal 
link is fundamentally distinct from a correlational link (Fig. 1d). 
Causal network inference is profoundly challenging15,16, and many 
methods for inferring regulatory networks connect correlated, 
or mutually dependent, nodes that might not have any causal 
relationship. Some approaches (e.g., directed acyclic graphs17–19) 
can in principle be used to infer causal relationships, but their 
success can be guaranteed only under strong assumptions15,20 
that are almost certainly violated in biological settings. This 
is due to many limitations—some possibly fundamental— 
in our ability to observe and perturb biological systems.
These observations imply that it is essential to undertake care-
ful empirical assessment in order to learn whether computational 
methods can provide causal insights in specific biological settings. 
Network inference methods are often assessed using data simulated 
from a known causal network structure (a so-called gold-standard 
network5,17). Such studies (and their synthetic biology counterparts21) 
are convenient and useful, but at the same time they are limited because 
it is difficult to truly mimic specific biological systems of interest. 
Inferred networks are often compared to the literature, but for the 
purpose of learning novel, potentially context-specific, regulatory 
relationships, this is an inherently limited approach, and experimental 
validation of network inference methods has remained limited9,10,19,22.
With the support of the Heritage Provider Network (HPN), 
we developed the HPN-DREAM challenge to assess the ability 
to learn causal networks and predict molecular time-course data. 
The Dialogue for Reverse Engineering Assessment and Methods 
(DREAM) project23 (http://dreamchallenges.org) has run several 
challenges focused on network inference22,24–27. Here we focused 
on causal signaling networks in human cancer cell lines. Protein 
assays were carried out using reverse-phase protein lysate arrays28,29 
(RPPAs) that included functional phosphorylated proteins.
The HPN-DREAM challenge comprised three sub-challenges. 
Sub-challenge 1 was to infer causal signaling networks using pro-
tein time-course data. To focus on networks specific to genetic and 
epigenetic background, the task spanned 32 different contexts, each 
defined by a combination of cell line and stimulus, and each with 
its own training and test data. The test data were used to assess the 
causal validity of inferred networks, as described below. A com-
panion in silico data task also focused on causal networks but by 
design did not allow the use of known biology. Sub-challenge 2 was 
to predict phosphoprotein time-course data under perturbation. 
This sub-challenge comprised both an experimental data task and 
an in silico data task, and the same training data sets were used 
as in sub-challenge 1. Sub-challenge 3 was to develop methods to 
visualize these complex, multidimensional data sets.
Across all sub-challenges, the scientific community contrib-
uted 178 submissions. In the network inference sub-challenge 
we found that several submissions achieved statistically signifi-
cant results, providing substantive evidence that causal network 
inference may be feasible in a complex, mammalian setting 
(we discuss a number of relevant caveats below). The use of 
pre-existing biological knowledge (e.g., from online databases) 
seemed to be broadly beneficial. However, FunChisq, a method 
that did not incorporate any known biology whatsoever, was not 
only the top performer in the in silico data task but also highly 
ranked in the experimental data task.
Challenge data, submissions and code have been made available 
as a community resource through the Synapse platform30, which 
was used to run the challenge (https://www.synapse.org/HPN_
DREAM_Network_Challenge; methods applied in the challenge 
are described in Supplementary Notes 1–3).
results
experimental training data
For the experimental data network inference task, partici-
pants were provided with RPPA phosphoprotein data from four 
breast cancer cell lines under eight ligand stimulus conditions31. 
The 32 (cell line, stimulus) combinations each defined a biologi-
cal context. Data for each context comprised time courses for ~45 
phosphoproteins (Supplementary Table 1). The training data 
included time courses obtained under three kinase inhibitors and a 
control (dimethyl sulfoxide (DMSO)) (Fig. 2a; details of the experi-
mental design, protocol, quality control and pre-processing can be 
found in the Online Methods). The data set is also available in an 
interactive online platform (http://dream8.dibsbiotech.com) that 
uses the Biowheel design developed by the winning team of the 
visualization sub-challenge.
Participants were tasked with using the training data to learn 
causal networks specific to each of the 32 contexts. Networks had 
to comprise nodes corresponding to each phosphoprotein with 
directed edges between the nodes. The edges were required to 
have weights indicating the strength of evidence in favor of each 
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bFigure 1 | Causal networks. (a) A directed edge denotes that inhibition 
of the parent node A can change the abundance of the child node B. 
(b) Causal edges, as used here, may represent direct effects or indirect 
effects that occur via unmeasured intermediate nodes. If node A causally 
influences node B via measured node C, the causal network should contain 
edges from A to C and from C to B, but not from A to B (top). However, 
if node C is not measured (and is not part of the network), the causal 
network should contain an edge from A to B (bottom). Note that in both 
cases inhibition of node A will lead to a change in node B. (c) Causal edges 
may depend on biological context; for example, a causal edge from A to B 
appears in context 1, but not in context 2 (lines in graphs are as defined 
in a). (d) Correlation and causation. Nodes A and B are correlated owing 
to regulation by the same node (C), but in this example no sequence of 
mechanistic events links A to B, and thus inhibition of A does not change 
the abundance of B (lines in bottom right graph are as defined in a). 
Therefore, despite the correlation, there is no causal edge from A to B.
np
g
© 
20
16
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
312  |  VOL.13  NO.4  |  APRIL 2016  |  nAture methods
AnAlysis
possible edge, but they did not need to indicate sign (i.e., whether 
activating or inhibitory). For the companion in silico data task, 
participants were provided with data generated from a nonlinear 
differential equation model of signaling12. The task was designed 
to mirror some of the key features of the experimental setup, 
and participants were asked to infer a single directed, weighted 
network (Online Methods and Supplementary Fig. 1). Whereas 
the experimental data task tested both data-driven learning and 
use of known biology, the in silico data task focused exclusively 
on the former, and for that reason node labels (i.e., protein names 
in the underlying model) were anonymized.
empirical assessment of causal networks
An incorrect causal network can score very well on standard sta-
tistical assessments of goodness of fit or predictive ability; for 
example, two nodes that are highly correlated but not causally 
linked (Fig. 1d) may predict each other well. For the experimental 
data task, we therefore developed a procedure that leveraged 
interventional data to assess inferred networks in a causal sense. 
The key idea was to assess the extent to which causal relation-
ships encoded in inferred networks agreed with test data obtained 
under an unseen intervention (Fig. 2a). Specifically, for a given 
context c, we identified the set of nodes that showed salient 
changes under a test inhibitor (here an mTOR inhibitor) relative 
to the DMSO-treated control (Fig. 2b and Online Methods). 
These nodes can be regarded as descendants of the inhibitor target 
(mTOR) in the underlying causal network for context c. We denote 
this gold-standard descendant set by Dc
GS (Supplementary Fig. 2). 
Note that Dc
GS may include both downstream nodes and those 
influenced via feedback loops within the experimental time 
frame. We emphasize that these ‘gold-standard’ sets are derived 
from (held-out) experimental data and should not be regarded as 
representing a fully definitive ground truth.
For each submitted context-specific network, we computed a 
predicted set of mTOR descendants (Dc
pred) and compared it with 
Dc
GS to obtain an area under the receiver operating characteristic 
curve (AUROC) score (Fig. 2c). Teams were ranked in each of the 
32 contexts by AUROC score, and the mean rank across contexts 
was used to provide an overall score and final ranking (Online 
Methods, Fig. 2d and Supplementary Fig. 3a). We tested the 
robustness of the rankings using a subsampling strategy (Online 
Methods). In addition to mean ranks, we used mean AUROC scores 
(across the contexts) in the analyses described below; these 
scores complement the mean ranks by giving information on the 
absolute level of performance, and the two metrics are highly 
correlated (Supplementary Fig. 3c).
For the in silico data task, the true causal network was known 
(Online Methods and Supplementary Fig. 4) and was used to 
obtain an AUROC score for each participant that determined the 
final rankings (Supplementary Fig. 3b).
An alternative scoring metric to AUROC is the area under 
the precision-recall curve (AUPR), which is often used when 
there is an imbalance between the number of positives and 
negatives in the gold standard32. Some of our settings were 
imbalanced, and we therefore compared rankings based on 
the AUROC and AUPR, which showed reasonable agreement 
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Figure 2 | The HPN-DREAM network inference 
challenge: overview of experimental data  
tasks and causal assessment strategy.  
(a) Protein data were obtained from four 
cancer cell lines under eight stimuli (described 
in ref. 31). For each of the 32 resulting 
contexts, participants were provided with 
training data comprising time courses for 
~45 phosphoproteins under three different 
kinase inhibitors and a control (DMSO). For 
the sub-challenge 1 experimental data task 
(SC1A), participants were asked to infer causal 
signaling networks specific to each context. In 
SC2A, the aim was to predict context-specific 
phosphoprotein time courses. In both cases, 
submissions were assessed using held-out, 
context-specific test data that were obtained 
under an unseen intervention (inhibition of 
the kinase mTOR). Each sub-challenge also 
included a companion in silico data task (SC1B 
and SC2B, respectively; described in the text, 
Online Methods and supplementary Fig. 1). 
Abund., abundance; TP, true positives; FP, false 
positives. (b) Networks submitted for SC1A were 
assessed causally in terms of agreement with 
the interventional test data. For each context, 
the set of nodes that changed under mTOR 
inhibition was identified (gold-standard causal 
descendants of mTOR; described in the text and 
Online Methods). In the example shown, node 
X is a descendant of mTOR, whereas node Y is 
not. (c) Predicted descendants of mTOR from 
submitted context-specific networks were compared with their experimentally determined gold-standard counterparts. This gave true and false positive 
counts and a (context-specific) AUROC. (d) In each context, teams were ranked by AUROC score, and mean rank across contexts gave the final rankings.
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(Online Methods and Supplementary 
Figs. 5 and 6).
Performance of individual teams and 
ensemble networks
Across the 32 contexts included in the 
experimental data network inference task 
(Fig. 3a), a mean of 11.8 teams (s.d. = 7.3; 
Supplementary Fig. 7 includes a full set of 
counts by context) achieved statistically sig-
nificant AUROC scores (FDR < 0.05; mul-
tiple testing correction performed within 
each context with respect to the number of 
teams; Online Methods). For the in silico 
data task, the top 14 teams achieved sig-
nificant AUROC scores (Supplementary 
Fig. 3b). The fact that several teams 
achieved significant scores with respect to 
causal performance metrics suggests that 
causal network inference may be feasible 
in this setting. Supplementary Table 2 
presents a summary of submissions.
Scores on the experimental data and 
in silico data network inference tasks were 
modestly correlated (r = 0.35, P = 0.011) but were better corre-
lated when only teams that did not use prior information were 
compared (r = 0.68, P = 0.002; Fig. 3b and Supplementary Note 
4). To identify teams that performed well across both tasks, we 
averaged ranks for experimental and in silico data tasks (Fig. 3b 
and Supplementary Fig. 3d).
To test the notion of ‘crowdsourcing’22,27,33,34 for causal net-
work inference, we combined inferred networks across all teams 
(Online Methods, Fig. 3c and Supplementary Fig. 8a). For the 
experimental data task, this ensemble or aggregate submission 
slightly outperformed the highest-ranked individual submis-
sion (mean AUROCs of 0.80 and 0.78, respectively), and for the 
in silico data task it ranked within the top five (AUROC of 0.67). 
Combinations of as few as 25% of randomly chosen submissions 
performed well on average (mean AUROCs of 0.72 and 0.64 
for experimental and in silico data tasks, respectively; Fig. 3d  
and Supplementary Fig. 8b).
Methodological details were provided by 41 of the 80 par-
ticipating teams (Supplementary Note 1), allowing us to 
classify submissions (Fig. 3e,f, Supplementary Table 2 and 
Supplementary Note 5). Similar to previous DREAM chal-
lenges22,33, we observed no clear relationship between method 
class and performance. We note that the boundaries between 
method classes are not always well defined and that additional 
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Figure 3 | Network inference sub-challenge 
(SC1) results. (a) AUROC scores in each of 
the 32 (cell line, stimulus) contexts for 
the 74 teams that submitted networks for 
the experimental data task. (b) Scores in 
experimental and in silico data tasks. Each 
square represents a team. Red borders around 
squares indicate that a different method 
was used in each task. Numbers adjacent to 
squares indicate ranks for the top ten teams 
under a combined score (three teams ranked 
third). (c,d) Results of crowdsourcing for the 
experimental data task. Aggregate networks  
were formed by combining, for each context, 
networks from top scoring (c) or randomly 
selected (d) teams (Online Methods). Dashed 
lines indicate aggregations of all submissions. 
Results in d are mean values over 100 iterations 
of random selection (error bars indicate ±s.d.).  
(e,f) Performance by method type for the 
experimental (e) and in silico (f) data tasks.  
The final rank is shown above each bar,  
and the gray lines indicate the mean 
performance of random predictions.  
ODE, ordinary differential equation.
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factors, including details of pre-processing 
and implementation, can be important.
top-performing methods for causal 
network inference
The best-scoring method for the experi-
mental data task, “PropheticGranger with 
heat diffusion prior,” by Team1, used a prior network created by 
averaging similarity matrices. The matrices were obtained via 
simulated heat diffusion applied to links derived from the Pathway 
Commons database35. The prior network was then coupled with 
an L1-penalized regression approach that considered not only past 
but also future time points (a detailed description is presented in 
Supplementary Note 1). The best scoring approach for the in silico 
data network inference task, and the most consistent performer 
across both data types, was the FunChisq method by Team7 
(Supplementary Note 1). This approach used a novel functional 
χ2 test to examine functional dependencies among the variables 
and did not use any biological prior information. Before FunChisq 
was applied, the abundance of each protein was discretized via the 
Ckmeans.1d.dp method36, with the number of discretization levels 
selected using the Bayesian information criterion on a Gaussian 
mixture model.
incorporating pre-existing biological knowledge
On average, teams that used prior biological information out-
performed those that did not (Fig. 4a; one-sided rank-sum test, 
P = 0.032). The submission ranked second used only a prior 
network and did not use the protein data. However, use of a prior 
network did not guarantee good performance, with mean AUROC 
scores ranging from 0.49 to 0.78 for teams using a prior network. 
Interestingly, the same prior network that was itself ranked 
second was used in both the top-performing submission and the 
submission ranked 43rd, the difference being the approach used 
to analyze the experimental data. Conversely, not using a prior 
network did not necessarily result in poor performance; mean 
AUROC scores ranged from 0.49 to 0.71 for teams not using a 
prior network. The top-performing teams using prior networks 
in the experimental data task did not perform as well in the 
in silico data task (Fig. 3b).
To further investigate the influence of known biology, we 
combined submitted prior networks to form an aggregate prior 
network (Online Methods). This outperformed the individual 
prior networks and had a score similar to that of the aggre-
gate submission described above (mean AUROC of 0.79). 
We combined the aggregate prior network with each of the two 
top methods (PropheticGranger and FunChisq) in varying pro-
portions (Fig. 4b). Combining FunChisq with the aggregate prior 
improved upon the aggregate prior alone (this was not the case for 
PropheticGranger). Finally, we considered three-way combina-
tions of PropheticGranger, FunChisq and the aggregate prior; the 
highest-scoring combination consisted of 20% PropheticGranger, 
50% FunChisq and 30% aggregate prior (mean AUROC of 0.82; 
Supplementary Fig. 9). We set the combination weights by 
optimizing performance on the test data; we note that because 
additional test data were not available, we could not rigorously 
assess the combination analyses.
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Figure 4 | Role of pre-existing biological 
knowledge in the experimental data network 
inference task (SC1A). (a) Box plots showing 
mean AUROC scores for teams that either 
did or did not use a prior network. P value 
calculated via Wilcoxon rank-sum test (n = 18). 
(b) Performance of aggregate prior network 
when combined with networks inferred by 
PropheticGranger (top performer in SC1A when 
combined with a network prior) or FunChisq 
(top performer in SC1B). The blue line indicates 
aggregate prior combined with randomly 
generated networks (mean of 30 random 
networks; shading indicates ±s.d.). The dashed 
line shows the mean AUROC score achieved by the 
top-performing team in SC1A. Error bars denote 
±s.e.m. (c) Performance of aggregate submission 
network and aggregate prior network in each 
context. Top, performance by context. Box plots 
over AUROC scores for the top 25 performers for 
each context, shown for comparison. Bottom, 
receiver operating characteristic curves for two 
contexts that showed performance differences 
between aggregate submission and prior.  
For all box plots, line within the box indicates 
the median, and the box edges denote the 25th 
and 75th percentiles. Whiskers extend to 1.5 
times the interquartile range from the box hinge. 
Individual data points are also shown.
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Context-specific performance
The overall score in the experimental data task was an average 
over all contexts; to gain additional insight, we further investi-
gated performance by context. In line with their good overall 
performance, aggregate submission and prior performed well 
relative to individual submissions in most contexts (Fig. 4c). 
The aggregate prior network performed particularly well for cell 
line MCF7 but less well for BT549, supporting the notion that 
biological contexts differ in the extent to which they agree with 
known biology. The aggregate submission offered the greatest 
improvements over the aggregate prior in settings where the 
aggregate prior performed less well, suggesting that combining 
data-driven learning with known biology might offer the most 
utility in noncanonical settings.
Crowdsourced context-specific signaling hypotheses
The context-specific aggregate submission networks (see Fig. 5a 
for an example) provided crowdsourced signaling hypotheses. 
Comparing the aggregate submission with the aggregate prior 
network helped to highlight potentially novel edges; we have pro-
vided a list of context-specific edges with their associated scores 
as a resource (Supplementary Table 3). Dimensionality reduction 
suggested that differences between cell lines were more promi-
nent than those between stimuli for a given cell line (Fig. 5b and 
Online Methods), in line with the notion that (epi)genetic back-
ground has a key role in determining network architecture.
time-course prediction sub-challenge
In the time-course prediction sub-challenge, participants 
predicted phosphoprotein time courses obtained under inter-
ventions not seen in the training data (Online Methods). We 
assessed predictions by direct comparison with the test data 
using root-mean-square (r.m.s.) error (Online Methods and 
Supplementary Note 6), focusing on predictive ability rather 
than causal validity. Supplementary Table 4 and Supplementary 
Note 2 present team scores and descriptions of submissions. 
Testing the robustness of team ranks gave two top performers 
for the experimental data task and a single top performer for the 
in silico data task (Online Methods).
The two top performers for the experimental data task took 
different approaches. Team42 (ranked second) simply calculated 
averages of values in the training data. Team10 (ranked third) 
used a truncated singular value decomposition to estimate param-
eters in a regression model. This method also ranked highly for the 
in silico data task and was the most consistent performer across 
both data types. Team44, the top-ranked team, was not eligible to 
be named as a top performer because of an incomplete submis-
sion (Supplementary Note 7), but their approach also consisted 
of calculating averages. The good performance of averaging may 
be explained to some degree by a shortcoming with the r.m.s. 
error metric used here (Supplementary Fig. 10). Team34, the 
top performer for the in silico data task, used a model informed 
by networks learned in the network inference sub-challenge. 
This suggests that networks can also have a useful role in purely 
predictive analyses.
Visualization sub-challenge
A total of 14 teams submitted visualizations that were made 
available to the HPN-DREAM Consortium members, who 
then voted for their favorite (Online Methods). The win-
ning entry, Biowheel, is designed to enhance the visualization 
of time-course protein data and aid in their interpretation 
(Supplementary Note 3). The data associated with a cell line 
are plotted to depict protein-abundance levels by color, as in a 
heat map, but are displayed as a ring, or wheel. Time is plotted 
along the radial axis and increases from the center outward. 
The interactive tool provides a way to mine data by displaying 
data subsets in various ways.
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Figure 5 | Aggregate submission networks for the experimental data network inference task (SC1A). (a) The aggregate submission network for cell line 
MCF7 under HGF stimulation. Line thickness corresponds to edge weight (number of edges shown set to equal number of nodes). To determine which edges 
were present and not present in the aggregate prior network, we placed a threshold of 0.1 on edge weights. Green and blue nodes represent descendants 
of mTOR in the network shown (Fig. 2b,c and supplementary Fig. 2). The network was generated using Cytoscape40. (b) Principal component analysis 
applied to edge scores for the 32 context-specific aggregate submission networks (Online Methods).
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disCussion
Inferring molecular networks remains a key open problem in 
computational biology. This study was motivated by the view 
that empirical assessment will be essential in catalyzing the 
development of effective methods for causal network inference. 
Such methods will be needed to systemically link molecular net-
works to the phenotypes they influence. Although causal network 
inference may fail for many theoretical and practical reasons, our 
results, obtained via a large-scale, community effort with blinded 
assessment, suggest that the task may be feasible in complex mam-
malian settings. By “feasible,” we mean capable of reaching a per-
formance level significantly better than that achieved by chance, 
and this was accomplished by a number of submissions, including 
approaches that did not use any prior information.
Our assessment approach focuses on causal validity and is gen-
eral enough to be applicable in a variety of settings, such as gene 
regulatory or metabolic networks. However, it is important to take 
note of several caveats. First, the procedure relies on the specifi-
city of test inhibitors. However, if the inhibitor were highly non-
specific, it would probably not be possible to achieve good results 
or for a prior network to perform well, because the predictions 
themselves are based on assumed specificity. In addition, data sug-
gest that the mTOR inhibitor used here is reasonably specific37. 
Second, the procedure used only one of the inhibitors for testing, 
whereas rankings could be changed by the inclusion of additional 
inhibitors. Hill et al.31 used a cross-validation–type scheme that 
iterated over inhibitors. Such an approach, although more com-
prehensive, is not possible in a ‘live’ challenge setting, as training 
and test data must be fixed at the outset. Third, the procedure 
does not distinguish between direct and indirect causal effects. 
Finally, all downstream nodes were weighted equally, regardless of 
whether they were context specific. Metrics that better emphasize 
context-specific effects will be an important avenue for future 
research and would probably shed further light on the utility of 
priors (which are not usually context specific). We also emphasize 
that further work is needed to clarify the theoretical properties of 
the score used here with respect to capturing agreement with the 
(unknown) ground truth.
Several submissions used novel methods or incorporated novel 
adaptations of existing methods (Supplementary Tables 2 and 4). 
Notably, the best-performing team for the network inference 
in silico data task developed a novel procedure (FunChisq) that 
also performed well on the experimental data task without use 
of prior information, increasing confidence in its robustness. 
Indeed, the ability to make such comparisons is a key benefit 
of running experimental and in silico challenges in parallel. 
Although some approaches performed well on one data type 
only (Fig. 3b), the overall positive correlation between experi-
mental and in silico scores is striking given that they were based 
on different data and assessment metrics. Teams that did not use 
prior information were relatively well correlated (Fig. 3b), sug-
gesting that good performers among these teams on the in silico 
data task could perform competitively on experimental data if 
their methods were extended to incorporate known biology.
The observation that prior information alone performs well 
reflects the fact that much is already known about signaling in 
cancer cells and suggests that causal networks are not entirely 
‘rewired’ in those cells. However, our analysis revealed contexts 
that deviate from known biology; such deviations are likely to 
be particularly important for understanding disease-specific 
dysregulation and therapeutic heterogeneity. Furthermore, it is 
possible that the literature is biased toward cancer, and for that 
reason priors based on the literature may be less effective in other 
disease settings. We anticipate that in the future a combination 
of known biology and data-driven learning will be important in 
elucidating networks in specific disease states.
A previous DREAM challenge also focused on signaling net-
works in cancer26. However, the scoring metric was predictive 
rather than causal (r.m.s. error between predicted and test data 
points) with a penalty related to sparseness of the inferred net-
work. Our assessment approach shares similarities with other 
approaches in the literature, including those used by Maathuis 
et al.38, who focused on inferring networks from static 
observational data, and Olsen et al.39, who used a different 
scoring metric, considering predicted downstream targets in 
close network proximity to the inhibited node.
It remains unclear to what extent the ranking of specific sub-
mitted methods could be generalized to different data types and 
biological processes. In our view, it is still too early to say whether 
there could emerge broadly effective ‘out-of-the-box’ methods for 
causal network inference analogous to methods used for some 
tasks in statistics and machine learning. Given the complexity of 
causal learning and the wide range of application-specific factors, 
we recommend that at the present time network inference efforts 
should whenever possible include some interventional data and 
that suitable scores, such as those described in this paper, be used 
for empirical assessment in the setting of interest.
methods
Methods and any associated references are available in the online 
version of the paper.
Accession codes. All data used for the challenge are available 
through Synapse under ID syn1720047.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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online methods
Challenge data. The HPN-DREAM network inference challenge 
comprised three sub-challenges: causal network inference (SC1), 
time-course prediction (SC2) and visualization (SC3). SC1 and 
SC2 each consisted of two tasks, one based on experimental data 
(SC1A and SC2A, respectively) and the other based on in silico 
data (SC1B and SC2B, respectively).
Experimental data. The experimental data and associated com-
ponents of the challenge are outlined in Figure 2a. Protein data 
from four breast cancer cell lines (UACC812, BT549, MCF7 and 
BT20) were provided for the challenge. All cell lines were acquired 
from ATCC, authenticated by short tandem repeat (STR) analy-
sis, and tested for mycoplasma contamination. These cell lines 
were chosen because they represent the major subtypes of breast 
cancer (basal, luminal, claudin-low and HER2-amplified) and are 
known to have different genomic aberrations41–43. Each cell line 
sample was treated with one of eight stimuli (serum, PBS, EGF, 
insulin, FGF1, HGF, NRG1 and IGF1). We refer to each of the 
32 possible combinations of cell line and stimulus as a biological 
context. For each context, data consisted of time courses for total 
proteins and post-translationally modified proteins, obtained 
under four different kinase inhibitors and a DMSO control. 
Full details of sample preparation, data generation, quality con-
trol and pre-processing steps can be found in ref. 31 and on the 
Synapse30 webpage describing the challenge (https://www.syn-
apse.org/HPN_DREAM_Network_Challenge). In brief, cell lines 
were serum-starved for 24 h and then treated for 2 h with an 
inhibitor (or combination of inhibitors) or DMSO vehicle alone. 
Cells were then either harvested (0 time point) or stimulated by 
one of the eight stimuli for 5, 15, 30 or 60 min or for 2, 4, 12, 24, 48 
or 72 h before protein harvest and analysis by RPPA at the MD 
Anderson Cancer Center Functional Proteomics Core Facility 
(Houston, Texas).
RPPA is an antibody-based assay that provides quantitative 
measurements of protein abundance28,44. The MD Anderson 
RPPA core facility maintains and updates a standard antibody 
list on the basis of antibody quality control as well as a variety of 
other factors, including scientific interest. Antibodies available for 
use in this assay are therefore enriched for components of receptor 
tyrosine kinase signaling networks and cancer-related proteins. 
For each cell line, we used the standard antibody list available at 
the time the assays were performed. We used 183 antibodies to 
target total (n = 132), cleaved (n = 3) and phosphorylated (n = 
48) proteins (the set of phosphoproteins varied slightly between 
cell lines; Supplementary Table 1). As part of the RPPA pipeline, 
we performed quality control to identify slides with poor anti-
body staining. Antibodies with poor quality control scores were 
excluded from the data set. During the challenge period, it became 
known to challenge organizers that several antibodies were of 
poor quality. Participants were advised not to include the associ-
ated data in their analyses, and these data were excluded from the 
scoring process. Measurements for each sample were corrected for 
protein loading, and several outlier samples with large correction 
factors were identified and removed. The UACC812 data were 
split across two batches. A batch-normalization procedure was 
applied31 to enable the data from the two batches to be combined. 
The experimental data used in the challenge are a subset of the 
data reported by Hill et al.31.
The inhibitors were chosen because they target key compo-
nents of the receptor tyrosine kinase signaling cascades assessed 
by the RPPA and are also relevant to breast cancer. Participants 
were provided with a training data set consisting of data for four 
out of the five inhibitor regimes (DMSO, PD173074 (FGFRi), 
GSK690693 (AKTi), and GSK690693 + GSK1120212 (AKTi + 
MEKi)). Note that there were no training data available for the 
AKTi + MEKi inhibitor regime for cell lines BT549 (all stimuli) 
and BT20 (PBS and NRG1 stimuli). Data for the remaining 
inhibitor (AZD8055 (mTORi)) formed a test data set, unseen by 
participants and used to evaluate submissions to the challenge.
The focus of the challenge was on short-term phosphoprotein 
signaling events and not on medium- to long-term changes over 
hours and days (for example, rewiring of networks due to epige-
netic changes arising from prolonged exposure to an inhibitor). 
Therefore the training data consisted only of phosphoprotein data 
(~45 phosphoproteins for each cell line) up to and including the 
4-h time point; in the challenge this data set was referred to as 
the main data set. In case some participants found the additional 
data useful, measurements for the remaining antibodies and time 
points were also made available in a ‘full’ data set. The test data 
(and challenge scoring) also focused only on phosphoproteins 
up to and including the 4-h time point. At the time of the chal-
lenge, all data were unpublished (the training data set was made 
available to participants through the Synapse platform).
In silico data. The in silico data and associated components of 
the challenge are outlined in Supplementary Figure 1. Simulated 
data were generated from a nonlinear ordinary differential equa-
tion (ODE) model of the ERBB signaling pathway. Specifically, the 
model was an extended version of the mass action kinetics model 
developed by Chen et al.12. Training data were simulated for 
20 network nodes (Supplementary Fig. 4; 14 phosphoproteins, 
two phospholipids, GTP-bound RAS and three dummy nodes that 
were unconnected in the network) under two ligand stimuli (each 
at two concentrations; applied individually and in combination) 
and under three inhibitors targeting specific nodes in the network 
or no inhibitor. Mirroring the experimental data, inhibitors were 
applied before ligand stimulation at t = 0. Time courses consisted 
of 11 time points (0, 1, 2, 4, 6, 10, 15, 30, 45, 60 and 120 min), 
and three technical replicates were provided for each sample. 
A measurement error model was developed to reflect the antibody- 
based readout of RPPAs and its technical variability. Node names 
were anonymized to prevent the use of prior information to trivi-
ally reconstruct the network. Further details of the simulation 
model can be found in Supplementary Note 8.
An in silico test data set was also generated to assess submissions 
to the time-course prediction sub-challenge and consisted of time 
courses for each node and stimulus, under in silico inhibition of each 
network node in turn. After the final team rankings for the in silico 
data task were calculated, two minor issues concerning the in silico 
test data were discovered. The issues were corrected, test data 
were regenerated, and final rankings and final leaderboards were 
updated. The top-performing teams remained unchanged after this 
update. Further details can be found in Supplementary Note 8.
Challenge questions and design. For the network inference 
sub-challenge experimental data task, participants were asked to 
use the training data to learn 32 signaling networks, one for each 
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of the (cell line, stimulus) contexts. Networks had to contain nodes 
for each phosphoprotein in the training data (node sets there-
fore varied depending on cell line), and network edges had to be 
directed (but unsigned). The networks were expected to describe 
causal edges, and this was reflected in the scoring (discussed 
below). A causal edge was defined as one for which inhibition of 
the parent node can result in a change in the abundance of the 
child node that is not fully mediated via any other measured node 
(but the influence can take place via unmeasured nodes; Fig. 1). 
Participants were asked to submit confidence scores (between 0 
and 1) for each possible directed edge in each network. Node names 
were not anonymized for the experimental data task, and par-
ticipants were allowed to use pre-existing biological information 
(e.g., from literature and online databases) in their analyses.
For the network inference sub-challenge in silico data task, 
participants were asked to infer a single network with 20 nodes 
(one for each variable in the training data) and directed edges 
corresponding to predicted causal relationships between the 
nodes. Submissions comprised a set of confidence scores for each 
possible directed edge in the network.
For the time-course prediction sub-challenge, participants 
were tasked with predicting time courses under interventions 
not contained in the training data set. For the experimental data 
task, predictions were requested for five test kinase inhibitors 
(participants were informed of the inhibitor targets). For each 
inhibitor, time courses consisting of seven time points (as in the 
training data) had to be predicted for each of the 32 contexts and 
for all phosphoproteins (except those targeted by the inhibitor). 
The in silico data task proceeded in an analogous fashion, with 
participants asked to predict time courses under inhibition of 
each of the 20 nodes in turn. Predicted time courses were required 
for each node for each of the eight stimulus contexts.
In the visualization sub-challenge, participants were asked to 
devise novel approaches to represent the data set provided with 
the challenge. The submission format was a schematic mock-up 
of the visualization.
The challenge was run over a period of 3 months. For the net-
work inference and time-course prediction sub-challenges, par-
ticipants were able to make submissions and obtain feedback via 
a leaderboard on a weekly basis (Supplementary Note 9). The 
frequency of feedback was chosen so as to obtain a balance 
between actively engaging participants and avoiding overfitting 
of models to the test data. To address this overfitting issue, other 
DREAM challenges34,45 used a second held-out test data set for 
final scoring of submissions. However, this was not possible here 
because of the small number of inhibitor conditions in the data.
As an incentive for participation, top-performing teams were 
awarded a modest cash prize (provided by HPN), invitations to 
present results at a conference and coauthor the paper describing 
the challenge, and (for SC1A only) the opportunity to have their 
method developed as a Cytoscape Cyni app39,46. Further details 
can be found on the Synapse web pages describing the challenge 
(https://www.synapse.org/HPN_DREAM_Network_Challenge) 
and in Supplementary Note 7.
Scoring procedure for the network inference sub-challenge 
experimental data task. Interventional test data. For the experi-
mental data task, we developed a scoring procedure that used 
held-out interventional data to assess the causal validity of 
networks submitted by participants. The procedure assessed the 
extent to which causal relationships encoded in network submis-
sions agreed with causal information contained in the test data. 
Using the held-out mTOR inhibitor data, we identified those 
phosphoproteins that showed a salient change in abundance under 
the inhibitor relative to the DMSO-treated control (Fig. 2b). 
Specifically, we let mi c,D  and mi c,I  denote the mean abundance levels 
of phosphoprotein i for (cell line, stimulus) context c under DMSO 
control conditions and mTOR inhibition, respectively (mean val-
ues were calculated over seven time points on log-transformed 
data; any replicates at each time point were averaged before the 
mean was taken). A paired t-test was used to assess whether mi c,D  
was significantly different from mi c,I , resulting in a P value pic for 
each phosphoprotein and context.
Some phosphoproteins show a clear stimulus response under 
DMSO, characterized by a marked increase and subsequent 
decrease in abundance over time (a ‘peak’ shape). In such cases, 
a change in abundance due to the mTOR inhibitor may be observ-
able only at intermediate time points. Because the paired t-test 
described above considers all time points, this effect may be 
masked. Therefore we used a heuristic to detect phosphoproteins 
with a peak-shaped time course under DMSO and re-performed 
the paired t-test over the intermediate time points within the peak 
only. The resulting P value was retained if smaller than the origi-
nal. For each context, a test was performed for each phosphopro-
tein. We corrected for multiple testing within each context using 
the median adaptive linear step-up procedure47, which resulted 
in q-values (FDR-adjusted P values) qic. Note that owing to the 
heuristic step, qic should not be interpreted formally.
For each context, a phosphoprotein was determined to have 
shown a change under the mTOR inhibitor if the following two 
conditions were satisfied: (1) qic < 0.05 and (2) m m si c i c i c, , ,D I− > , 
where σi,c is the pooled replicate s.d. for the DMSO and mTOR 
inhibitor data. The second condition acted as a conservative filter 
to ensure that effect sizes were not small relative to replicate vari-
ation. We worked under the assumption that mTOR inhibition 
would lead to changes in the abundance of all descendants of 
mTOR in the underlying context-specific causal network (i.e., 
that changes would be observed in any node for which a directed 
path existed from mTOR to that node; this included downstream 
nodes as well as those influenced via feedback loops within the 
timescale of the experiments). This procedure resulted in con-
text-specific gold-standard sets of causal descendants of mTOR 
D i qc i c i c i c i c
GS D Iand= < − >{ }: , , , ,.0 05 m m s  (Supplementary Fig. 2).
The scoring metric. For each context c, we compared the gold-
standard descendant set DcGS (obtained from the held-out test data) 
with predicted descendant sets obtained from context-specific 
networks submitted by participants (Fig. 2c). For context c, 
a submitted network consisted of edge confidence scores for 
each possible directed edge. Placing a threshold τ on edge scores 
resulted in a network structure consisting only of those edges 
with a score greater than τ, and from this network we obtained a 
predicted set of descendants of mTOR (at threshold τ), denoted 
by Dcpred( )t . Comparing Dcpred t( ) with DcGS gave the number of 
predicted descendants that were correct (true positives; TP (τ)) 
and the number of predicted descendants that were incorrect 
(false positives; FP(τ)). Varying the threshold τ and plotting 
TP(τ) against FP(τ) resulted in a receiver operating character-
istic curve, and the scoring metric was the area under this curve 
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(normalized to be between zero and one; AUROC). For each team, 
AUROC scores were calculated for each of the 32 contexts.
The statistical significance of AUROC scores was determined 
using simulated null distributions, generated by calculating 
AUROC scores for 100,000 random networks, each consisting 
of random edge scores (drawn independently from the uniform 
distribution on the unit interval [0,1]). Gaussian fits to the null 
distributions were used to calculate P values. For each context, 
the set of P values (across all teams) underwent multiple test-
ing correction using the Benjamini-Hochberg FDR procedure. 
There were two contexts (BT549, NRG1 and BT20, insulin) for 
which no team achieved a statistically significant (FDR < 0.05) 
AUROC score (Supplementary Fig. 7b). These two contexts were 
therefore regarded as too challenging and were disregarded in the 
scoring procedure.
Teams were ranked in each context according to AUROC score. 
The resulting 30 rank scores for each team were then averaged 
to obtain a mean rank score. Final team rankings were obtained 
using mean rank scores (Fig. 2d).
During the challenge period, participants were informed only 
that submitted networks would be scored using test data obtained 
under interventions not present in the training data; details of the 
scoring procedure and the identity, nature and number of inter-
ventions in the test data were not revealed. Note that participants 
knew the identities of inhibitors in the training data.
Gold-standard network and scoring metric for the network 
inference sub-challenge in silico data task. The true causal 
network underlying the variables in the in silico data was 
obtained from the data-generating nonlinear ODE model 
(Supplementary Fig. 4). However, deriving the causal network 
from the equations was not trivial because the model contained 
more variables than the 20 variables present in the challenge 
data and some variables appeared in the model in complexes. 
Details of how the causal network was obtained can be found in 
Supplementary Note 8.
Each team submitted a single network consisting of a set of edge 
scores. This was compared directly to the gold-standard causal 
network to produce a receiver operating characteristic curve 
(by calculating the number of true positive and false positive 
edges at various edge score thresholds), and the AUROC was used 
as the scoring metric. Self-edges were not considered for scoring. 
The statistical significance of AUROC scores was determined 
analogously to the experimental data task.
Alternative scoring metrics for the network inference sub- 
challenge. We used AUROC as the scoring metric for the network 
inference sub-challenge, but we note that alternative metrics could 
have been used. In particular, the AUPR is often used when there 
is an imbalance between the number of positives and negatives in 
the gold standard32. Although many contexts in the experimental 
data task had a reasonable balance (median ratio of negatives to 
positives of 1.71), some contexts had many more negatives than 
positives, and there was also an imbalance for the in silico data 
task (ratio of negatives to positives of 4.14; Supplementary Fig. 5). 
Therefore AUPR could have been an appropriate choice in sev-
eral cases. For this reason, at the end of the challenge period we 
performed comparisons of final team rankings (obtained using 
AUROC) to rankings obtained using AUPR or a combination of 
AUROC and AUPR (Supplementary Fig. 6). For the experimental 
data task, the AUROC-based rankings showed good agreement 
with those obtained under either alternative metric. Agreement 
was not as strong for the in silico data task, but it was still rea-
sonable, with all metrics resulting in the same top performer. 
Furthermore, of the top ten teams under AUROC, only two were 
outside the top ten under AUPR, and they ranked 12th and 13th. 
Similarly, only two of the top ten teams under AUPR were not 
in the top ten under AUROC, and they ranked 11th and 12th. 
For openness and transparency, scores and rankings based on 
AUPR and the combination metric were included in the final 
leaderboards (available through Synapse at https://www.synapse.
org/HPN_DREAM_Network_Challenge; combination metric 
scores are also included in Supplementary Table 2).
Scoring metric for the time-course prediction sub-challenge. 
For both experimental data and in silico data, predictions of 
context-specific time courses under inhibitors not contained in 
the training data were directly compared against context-specific 
test data obtained under the corresponding inhibitor. Prediction 
accuracy was quantified using r.m.s. error with comparisons made 
on log-transformed data after averaging of replicates. The r.m.s. 
error scores were calculated separately for parts of the data that 
could potentially be on different scales. We refer to each portion 
of the data where an r.m.s. error score was calculated as a ‘data 
block’. Teams were ranked within each data block, and a mean 
rank was calculated to obtain a final ranking. Some blocks of 
data, where no team achieved a statistically significant score, were 
disregarded in the scoring procedure (Supplementary Tables 5 
and 6; FDR < 0.05). Full details of the scoring are presented in 
Supplementary Note 6.
Visualization sub-challenge scoring. HPN-DREAM challenge 
participants scored submitted visualization proposals. Thirty-six 
participants cast votes by assigning ranks (from 1 to 3) to their 
three favorite submissions (the remaining submissions were all 
assigned a rank of 4). Teams were then ranked according to mean 
rank across the 36 votes (Supplementary Fig. 11).
Robustness of ranking under subsampling. To ensure that team 
rankings were robust in the network inference and time-course 
prediction sub-challenges, we performed a subsampling analysis 
in which, for each of 100 iterations, 50% of the test data were 
removed at random and rankings of submissions were recalcu-
lated using the remaining test data. Team A was considered to be 
robustly ranked above team B if the former outranked the latter 
in at least 75% of iterations.
For the network inference sub-challenge experimental data 
task, we subsampled test data by either (i) removing 50% of the 
phosphoproteins for each (cell line, stimulus) context when mak-
ing comparisons between gold-standard and predicted descend-
ant sets (Supplementary Fig. 12a) or (ii) removing 50% of the 
contexts (i.e., scoring was based on 15 contexts instead of 30; 
Supplementary Fig. 12b). The top team (Team1) outranked 
the team ranked second (Team2) in 76% and 97% of iterations 
for subsampling methods i and ii, respectively. For the network 
inference sub-challenge in silico data task, 50% of the edges (and 
non-edges) in the gold-standard network were used for scoring 
(Supplementary Fig. 12c). The top-scoring performer (Team7) 
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had a higher AUROC score than the team ranked second (Team11) 
in 89% of the subsampling iterations.
For the experimental and in silico data tasks in the time-course 
prediction sub-challenge, we subsampled test data by either (i) 
removing 50% of the data blocks or (ii) subsampling 50% of the 
data points within each data block. For the experimental data 
task, the top-ranked team (Team44) outranked the team ranked 
second (Team42) in 90% and 54% of iterations for subsampling 
methods i and ii, respectively. Because the 75% threshold was 
not met for one of the subsampling methods, Team44 was not 
regarded as ranked robustly above Team42. Team42 outranked the 
team ranked third (Team10) in 60% and 70% of iterations and so, 
again, the ranking was not regarded as robust. However, Team10 
was robustly ranked above the team ranked fourth (93% and 94% 
of iterations). Team44 was not eligible to be named as a top per-
former because of an incomplete submission (Supplementary 
Note 7), and so the teams ranked second and third (Team42 and 
Team10, respectively) were named as top performers. For the 
in silico data task, the top team (Team34) outranked the team 
ranked second in 95% and 100% of iterations for subsampling 
methods i and ii, respectively.
Crowdsourced analyses: aggregate submission networks and 
aggregate prior network. We obtained aggregate submission net-
works by integrating predicted networks across all teams (to avoid 
bias, we used a filtering process to remove correlated submissions 
from the aggregation; 66 and 58 teams formed the aggregate net-
works for the experimental and in silico data tasks, respectively; 
Supplementary Note 10 and Supplementary Table 2). For the 
experimental data task, an aggregate network was formed for each 
of the 32 contexts. Each aggregate submission network consisted 
of a set of edge scores, calculated by taking the mean of scores 
submitted by teams for each edge. To ensure that edge scores were 
comparable across teams, we scaled scores for each team before 
aggregation so that the maximum edge score (across all 32 con-
texts for the experimental data task) had a value of one.
For the experimental data task, an aggregate prior network 
was formed in an analogous manner to the aggregate submission 
networks, using ten prior networks provided by teams (the prior 
network submitted by Team2 was also used by several other teams 
but was included only once in the aggregation; Supplementary 
Table 2). Individual prior networks, and therefore the aggregate 
prior network, were not context specific.
Principal component analysis of context-specific aggregate 
submission networks. The 32 context-specific aggregate submis-
sion networks for the network inference sub-challenge experi-
mental data task were combined into a matrix E of edge scores in 
which columns corresponded to contexts and rows corresponded 
to edges (only network nodes common to all contexts were 
considered for this analysis). Each row of matrix E contained 
the scores for a specific edge in each of the contexts. Principal 
component analysis was performed on this matrix using the 
MATLAB function princomp.
Web-based community resource. A community resource has 
been made available through the Synapse platform at https://www.
synapse.org/HPN_DREAM_Network_Challenge under the sec-
tion titled “HPN-DREAM Community Resource.” This resource 
includes all challenge data, participant submissions, participant 
code, participant prior networks and crowdsourced aggregate net-
works. Code for scoring submissions is available as part of the 
DREAMTools software package48 (Supplementary Note 11).
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